The Immunohistochemistry Antibody Company

Home
Products
- All Antibodies
- IHC-plus Antibodies
Services
- Immunohistochemistry Studies
- Tissue Cross-Reactivity Screening
Distributors
Resources
- About our Tissue Bank
- Customer Support
- How to Buy
- IHC-plus Protocol
- LSBio Media
- Publications
- Antibody Reports
Company
- About LifeSpan
- Press Releases
- Holiday Schedule
- Contact Us

View Cart

Lung Cancer Screen 79 Tissue Microarray - LS-SLUCA79

This tissue microarray is available for use in LSBio Immunohistochemistry Studies only.

Technical Help email

Request an IHC Study by email

PDF Spec Sheet - click here

Catalog ID:	LS-SLUCA79
Product Name:	Lung Cancer Screen 79
Description:	Non-small cell lung carcinoma (NSCLC) with stage/grade
Format:	FFPE
Category:	Human Tumor
QA/QC:	H&E reviewed
Storage:	Short term RT; Long term 4ºC
Clinical History:	No
Tissue Marker:	No
Stage/Grade:	Yes
Cases:	50
Cores:	100
Slides Per Set:	1

LS-SLUCA79 Tissue Microarray Map

Slide Number 1

LABEL

	1	2	3	4	5	6	7	8	9	10
A	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
B	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
C	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
D	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
E	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
F	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
G	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
H	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
I	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng
J	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng	Lng

Diagnosis Type Legend

Benign non-neoplastic

Diseased

Inflammatory

Malignant

Metastatic

Tumor

Unknown

Element Tissue Legend

Lung (Lng); Lung, Cartilage and gland tissue (Lng);

LS-SLUCA79 Element Details

Slide	Position	Species	Gender	Age	Tissue	Diagnosis	Diagnosis Type	TNM Tumor Classification	Tumor Grade	Tumor Stage
1	A1	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	A2	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	A3	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	A4	Human	M	51 y	Lung, Cartilage and gland tissue (Lng)	Squamous cell carcinoma	Malignant	T2N1M0		IIB
1	A5	Human	F	69 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T2N0M0	2	I
1	A6	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	A7	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	A8	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0		IIB
1	A9	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	A10	Human	F	69 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T2N0M0	2	I
1	B1	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	B2	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B3	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B4	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma with chronic inflammation	Malignant	T1N1M0		II
1	B5	Human	M	49 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T4N0M0	2	III
1	B6	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	B7	Human	M	64 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	B8	Human	M	56 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T2N0M0	2	I
1	B9	Human	M	61 y	Lung (Lng)	Squamous cell carcinoma with chronic inflammation	Malignant	T1N1M0		II
1	B10	Human	M	49 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T4N0M0	2	III
1	C1	Human	M	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	C2	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	C3	Human	M	58 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	C4	Human	M	69 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	C5	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2-3	I
1	C6	Human	M	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	C7	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N0M0	2	I
1	C8	Human	M	58 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2	I
1	C9	Human	M	69 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	C10	Human	M	72 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	2-3	I
1	D1	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	D2	Human	M	37 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	D3	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	3	IIIA
1	D4	Human	M	67 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	D5	Human	F	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	3	IIIA
1	D6	Human	M	60 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	D7	Human	M	37 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	2	IIB
1	D8	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	3	IIIA
1	D9	Human	M	67 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	D10	Human	F	54 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N2M0	3	IIIA
1	E1	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	E2	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	E3	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T3N0M0	3	IIIA
1	E4	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	E5	Human	M	57 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	2	IIB
1	E6	Human	M	65 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	E7	Human	M	50 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T2N1M0	3	IIB
1	E8	Human	M	51 y	Lung (Lng)	Squamous cell carcinoma with necrosis	Malignant	T3N0M0	3	IIIA
1	E9	Human	M	66 y	Lung (Lng)	Squamous cell carcinoma	Malignant	T1N0M0	3	I
1	E10	Human	M	57 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	2	IIB
1	F1	Human	F	70 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	1	I
1	F2	Human	M	57 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	1	IIB
1	F3	Human	F	54 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	IIB
1	F4	Human	F	50 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	2	I
1	F5	Human	M	34 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	IIB
1	F6	Human	F	70 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	1	I
1	F7	Human	M	57 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	1	IIB
1	F8	Human	F	54 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	IIB
1	F9	Human	F	50 y	Lung (Lng)	Adenocarcinoma	Malignant	T1N0M0	2	I
1	F10	Human	M	34 y	Lung (Lng)	Adenocarcinoma, Papillary	Malignant	T2N1M0	2	IIB
1	G1	Human	M	64 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N3M0	2	IIIB
1	G2	Human	F	52 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	2	IIB
1	G3	Human	M	60 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	2	IIB
1	G4	Human	F	49 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	G5	Human	M	54 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	G6	Human	M	64 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N3M0	2	IIIB
1	G7	Human	F	52 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	2	IIB
1	G8	Human	M	60 y	Lung (Lng)	Adenocarcinoma with necrosis	Malignant	T2N1M0	2	IIB
1	G9	Human	F	49 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	G10	Human	M	54 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H1	Human	M	59 y	Lung (Lng)	Adenocarcinoma with necrosis	Malignant	T2N1M0		IIB
1	H2	Human	M	62 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H3	Human	M	71 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H4	Human	M	37 y	Lung (Lng)	Adenocarcinoma, Mucinous and solid	Malignant	T2N2M0		IIIA
1	H5	Human	M	64 y	Lung (Lng)	Large cell carcinoma	Malignant	T3N2M0		IIIA
1	H6	Human	M	59 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H7	Human	M	62 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H8	Human	M	71 y	Lung (Lng)	Adenocarcinoma	Malignant	T2N1M0	3	IIB
1	H9	Human	M	37 y	Lung (Lng)	Adenocarcinoma, Mucinous and solid	Malignant	T2N2M0		IIIA
1	H10	Human	M	64 y	Lung (Lng)	Large cell carcinoma	Malignant	T3N2M0		IIIA
1	I1	Human	F	21 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I2	Human	F	21 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I3	Human	F	40 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I4	Human	F	40 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I5	Human	M	38 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I6	Human	F	21 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I7	Human	F	21 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I8	Human	F	40 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I9	Human	F	40 y	Lung (Lng)	Normal	Benign non-neoplastic
1	I10	Human	M	38 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J1	Human	M	24 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J2	Human	M	49 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J3	Human	M	55 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J4	Human	M	50 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J5	Human	M	47 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J6	Human	M	24 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J7	Human	M	49 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J8	Human	M	55 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J9	Human	M	50 y	Lung (Lng)	Normal	Benign non-neoplastic
1	J10	Human	M	47 y	Lung (Lng)	Normal	Benign non-neoplastic

PLEASE NOTE

For RESEARCH USE ONLY. Not intended for human diagnostic or therapeutic purposes.

Not for resale without prior written consent from LifeSpan BioSciences, Inc.